238
Views
5
CrossRef citations to date
0
Altmetric
Review

Drug treatment options for acute promyelocytic leukemia

, &
Pages 117-127 | Received 11 May 2021, Accepted 26 Jul 2021, Published online: 05 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jingli Liu, Tonia Hermon, Xiaohua Gao, Darlene Dixon & Hang Xiao. (2023) Arsenic and diabetes mellitus: a putative role for the immune system. All Life 16:1.
Read now

Articles from other publishers (4)

Antónia Gonçalves, Fernando Rocha & Berta N. Estevinho. (2023) Pharmaceutical/Clinical Strategies in the Treatment of Acute Promyelocytic Leukemia: All-Trans Retinoic Acid Encapsulation by Spray-Drying Technology as an Innovative Approach–Comprehensive Overview. Pharmaceuticals 16:2, pages 180.
Crossref
Yanfeng Liu, Yan Jia, Yi Liu, Xuefeng Chen & Mei Zhang. (2022) Tetra-arsenic tetra-sulfide enhances NK-92MI mediated cellular immunotherapy in all-trans retinoic acid-resistant acute promyelocytic leukemia. Investigational New Drugs 40:6, pages 1231-1243.
Crossref
Pan Pantziarka & Sarah Blagden. (2022) Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome. Cancers 14:7, pages 1621.
Crossref
Mengyu Xiao, Pan Zhou & Kai Sun. (2022) Effect of Therapeutically Related Drugs on Coagulation-Anticoagulation Balance in Acute Promyelocytic Leukemia. Clinical and Applied Thrombosis/Hemostasis 28, pages 107602962210801.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.